OTC Healthcare in the Czech Republic to 2014

Typ der Studie:	Marktstudie
Jahrgang:	01/2011
Herausgeber:	Datamonitor
Sprachversion:	Englisch
Verfügbarkeit:	Lieferbar

Preis**
(Lieferformat):

495,00$ netto PDF-Datei per E-Mail

Versandkostenfrei

** WICHTIG:
Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%).

Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs.

Zahlen und Fakten zur Studie:

Databook

170 seiten

Inhalt der Studie:

Introduction

This databook provides key data and information on the OTC healthcare market in the Czech Republic. This report is a comprehensive resource for market, category and segm.....

Mehr über diese Studie

Introduction

This databook provides key data and information on the OTC healthcare market in the Czech Republic. This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

Provides information on ten key categories within the OTC Healthcare market

Market,category and segment level information on value with historic (2004-09) and forecast (2010-14) data

Category level company and brand share as well as distribution share information for 2008 and 2009

Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in the Czech Republic increased at a compound annual growth rate of 7.6% between 2004 and 2009.

The traditional medicines category led the OTC healthcare market in the Czech Republic, accounting for a share of 28.4%.

The leading players in the Czech Republican OTC healthcare market are Johnson & Johnson, GlaxoSmithKline Plc and Zentiva NV.

Reasons to Purchase

Develop business strategies by understanding the quantitative trends within the OTC healthcare market in the Czech Republic

Design effective marketing and sales strategies by identifying key market categories and segments

Identify key players within the market to plan lucrative M&A, partnerships and agreements

[Studien Infos ausblenden]

Inhaltsverzeichnis

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 Market Overview 30
Value analysis (Czech Koruna), 2004?09 30
Value analysis (Czech Koruna), 2009?14 32
Value analysis (US dollars), 2004?09 34
Value analysis (US dollars), 2009?14 35
Company and brand share analysis 37
Distribution analysis 44
Chapter 4 Leading Company Profiles 46
Johnson & Johnson 46
GlaxoSmithKline Plc 48
Chapter 5 Category Analysis: Analgesics 51
Value analysis (Czech Koruna), 2004?09 51
Value analysis (Czech Koruna), 2009?14 52
Value analysis (US dollars), 2004?09 54
Value analysis (US dollars), 2009?14 54
Company and brand share analysis 56
Distribution analysis 59
Chapter 6 Category Analysis: Topical OTC Medicines 61
Value analysis (Czech Koruna), 2004?09 61
Value analysis (Czech Koruna), 2009?14 62
Value analysis (US dollars), 2004?09 64
Value analysis (US dollars), 2009?14 65
Company and brand share analysis 67
Distribution analysis 70
Chapter 7 Category Analysis: Cough and Cold Preparations 72
Value analysis (Czech Koruna), 2004?09 72
Value analysis (Czech Koruna), 2009?14 73
Value analysis (US dollars), 2004?09 75
Value analysis (US dollars), 2009?14 76
Company and brand share analysis 78
Distribution analysis 81
Chapter 8 Category Analysis: Indigestion Preparations 83
Value analysis (Czech Koruna), 2004?09 83
Value analysis (Czech Koruna), 2009?14 84
Value analysis (US dollars), 2004?09 86
Value analysis (US dollars), 2009?14 86
Company and brand share analysis 88
Distribution analysis 91
Chapter 9 Category Analysis: Medicated Skin Products 93
Value analysis (Czech Koruna), 2004?09 93
Value analysis (Czech Koruna), 2009?14 94
Value analysis (US dollars), 2004?09 96
Value analysis (US dollars), 2009?14 97
Company and brand share analysis 99
Distribution analysis 102
Chapter 10 Category Analysis: First Aid Kits 104
Value analysis (Czech Koruna), 2004?09 104
Value analysis (Czech Koruna), 2009?14 105
Value analysis (US dollars), 2004?09 106
Value analysis (US dollars), 2009?14 106
Company and brand share analysis 107
Distribution analysis 109
Chapter 11 Category Analysis: Other OTC Healthcare Products 111
Value analysis (Czech Koruna), 2004?09 111
Value analysis (Czech Koruna), 2009?14 112
Value analysis (US dollars), 2004?09 114
Value analysis (US dollars), 2009?14 115
Company and brand share analysis 117
Distribution analysis 120
Chapter 12 Category Analysis: Plasters & Bandages 122
Value analysis (Czech Koruna), 2004?09 122
Value analysis (Czech Koruna), 2009?14 123
Value analysis (US dollars), 2004?09 125
Value analysis (US dollars), 2009?14 126
Company and brand share analysis 128
Distribution analysis 131
Chapter 13 Category Analysis: Traditional Medicines 133
Value analysis (Czech Koruna), 2004?09 133
Value analysis (Czech Koruna), 2009?14 134
Value analysis (US dollars), 2004?09 135
Value analysis (US dollars), 2009?14 135
Company and brand share analysis 136
Distribution analysis 139
Chapter 14 Category Analysis: Vitamins and Minerals 141
Value analysis (Czech Koruna), 2004?09 141
Value analysis (Czech Koruna), 2009?14 142
Value analysis (US dollars), 2004?09 144
Value analysis (US dollars), 2009?14 144
Company and brand share analysis 146
Distribution analysis 149
Chapter 15 Country Comparison 151
Value 151
Market share 155
Chapter 16 New Product Development 156
Product launches over time 156
Recent product launches 159
Chapter 17 Macroeconomic Profile 160
Macroeconomic Indicators 160
Chapter 18 Research Methodology 165
Methodology overview 165
Secondary research 166
Market modeling 167
Creating an initial data model 167
Revising the initial data model 167
Creating a final estimate 168
Creating demographic value splits 168
Primary research 168
Data finalization 169
Ongoing research 169
Chapter 19 Appendix 170
Future readings 170
How to contact experts in your industry 170
Disclaimer 170

LIST OF FIGURES
Figure 1: OTC healthcare, Czech Republic, value by category (CZKm), 2004?14 33
Figure 2: OTC healthcare, Czech Republic, category growth comparison, by value, 2004?14 36
Figure 3: OTC healthcare, Czech Republic, company share by value (%), 2008?09 41
Figure 4: OTC healthcare, Czech Republic, distribution channels by value (%), 2008?09 45
Figure 5: Analgesics, Czech Republic, value by segment (CZKm), 2004?14 53
Figure 6: Analgesics, Czech Republic, category growth comparison, by value, 2004?14 55
Figure 7: Analgesics, Czech Republic, company share by value (%), 2008?09 57
Figure 8: Analgesics, Czech Republic, distribution channels by value (%), 2008?09 60
Figure 9: Topical OTC medicines, Czech Republic, value by segment (CZKm), 2004?14 63
Figure 10: Topical OTC medicines, Czech Republic, category growth comparison, by value, 2004?14 66
Figure 11: Topical OTC medicines, Czech Republic, company share by value (%), 2008?09 68
Figure 12: Topical OTC medicines, Czech Republic, distribution channels by value (%), 2008?09 71
Figure 13: Cough and cold preparations, Czech Republic, value by segment (CZKm), 2004?14 74
Figure 14: Cough and cold preparations, Czech Republic, category growth comparison, by value, 2004?14 77
Figure 15: Cough and cold preparations, Czech Republic, company share by value (%), 2008?09 79
Figure 16: Cough and cold preparations, Czech Republic, distribution channels by value (%), 2008?09 82
Figure 17: Indigestion preparations, Czech Republic, value by segment (CZKm), 2004?14 85
Figure 18: Indigestion preparations, Czech Republic, category growth comparison, by value, 2004?14 87
Figure 19: Indigestion preparations, Czech Republic, company share by value (%), 2008?09 89
Figure 20: Indigestion preparations, Czech Republic, distribution channels by value (%), 2008?09 92
Figure 21: Medicated skin products, Czech Republic, value by segment (CZKm), 2004?14 95
Figure 22: Medicated skin products, Czech Republic, category growth comparison, by value, 2004?14 98
Figure 23: Medicated skin products, Czech Republic, company share by value (%), 2008?09 100
Figure 24: Medicated skin products, Czech Republic, distribution channels by value (%), 2008?09 103
Figure 25: First aid kits, Czech Republic, value (CZKm), 2004?14 105
Figure 26: First aid kits, Czech Republic, distribution channels by value (%), 2008?09 110
Figure 27: Other OTC healthcare products, Czech Republic, value by segment (CZKm), 2004?14 113
Figure 28: Other OTC healthcare products, Czech Republic, category growth comparison, by value, 2004?14 116
Figure 29: Other OTC healthcare products, Czech Republic, company share by value (%), 2008?09 118
Figure 30: Other OTC healthcare products, Czech Republic, distribution channels by value (%), 2008?09 121
Figure 31: Plasters & bandages, Czech Republic, value by segment (CZKm), 2004?14 124
Figure 32: Plasters & bandages, Czech Republic, category growth comparison, by value, 2004?14 127
Figure 33: Plasters & bandages, Czech Republic, company share by value (%), 2008?09 129
Figure 34: Plasters & bandages, Czech Republic, distribution channels by value (%), 2008?09 132
Figure 35: Traditional medicines, Czech Republic, value (CZKm), 2004?14 134
Figure 36: Traditional medicines, Czech Republic, company share by value (%), 2008?09 137
Figure 37: Traditional medicines, Czech Republic, distribution channels by value (%), 2008?09 140
Figure 38: Vitamins and minerals, Czech Republic, value by segment (CZKm), 2004?14 143
Figure 39: Vitamins and minerals, Czech Republic, category growth comparison, by value, 2004?14 145
Figure 40: Vitamins and minerals, Czech Republic, company share by value (%), 2008?09 147
Figure 41: Vitamins and minerals, Czech Republic, distribution channels by value (%), 2008?09 150
Figure 42: Global OTC healthcare market split (value terms, 2009), top five countries 152
Figure 43: Global OTC healthcare market value, 2004–09, top five countries 154
Figure 44: Annual data review process 166

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: OTC healthcare, Czech Republic, value by category (CZKm), 2004?09 31
Table 4: OTC healthcare, Czech Republic, value forecast by category (CZKm), 2009?14 32
Table 5: OTC healthcare, Czech Republic, value by category ($m), 2004?09 34
Table 6: OTC healthcare, Czech Republic, value forecast by category ($m), 2009?14 35
Table 7: OTC healthcare, Czech Republic, brand share by value (%), 2008?09 37
Table 8: OTC healthcare, Czech Republic, value by brand (CZKm), 2008?09 39
Table 9: OTC healthcare, Czech Republic, company share by value (%), 2008?09 42
Table 10: OTC healthcare, Czech Republic, value by company (CZKm), 2008?09 43
Table 11: OTC healthcare, Czech Republic, distribution channels by value (%), 2008?09 44
Table 12: OTC healthcare, Czech Republic, value by distribution channel (CZKm), 2008?09 44
Table 13: Johnson & Johnson key facts 46
Table 14: GlaxoSmithKline Plc key facts 48
Table 15: Analgesics, Czech Republic, value by segment (CZKm), 2004?09 51
Table 16: Analgesics, Czech Republic, value forecast by segment (CZKm), 2009?14 52
Table 17: Analgesics, Czech Republic, value by segment ($m), 2004?09 54
Table 18: Analgesics, Czech Republic, value forecast by segment ($m), 2009?14 54
Table 19: Analgesics, Czech Republic, brand share by value (%), 2008?09 56
Table 20: Analgesics, Czech Republic, value by brand (CZKm), 2008?09 56
Table 21: Analgesics, Czech Republic, company share by value (%), 2008?09 58
Table 22: Analgesics, Czech Republic, value by company (CZKm), 2008?09 58
Table 23: Analgesics, Czech Republic, distribution channels by value (%), 2008?09 59
Table 24: Analgesics, Czech Republic, value by distribution channel (CZKm), 2008?09 59
Table 25: Topical OTC medicines, Czech Republic, value by segment (CZKm), 2004?09 61
Table 26: Topical OTC medicines, Czech Republic, value forecast by segment (CZKm), 2009?14 62
Table 27: Topical OTC medicines, Czech Republic, value by segment ($m), 2004?09 64
Table 28: Topical OTC medicines, Czech Republic, value forecast by segment ($m), 2009?14 65
Table 29: Topical OTC medicines, Czech Republic, brand share by value (%), 2008?09 67
Table 30: Topical OTC medicines, Czech Republic, value by brand (CZKm), 2008?09 67
Table 31: Topical OTC medicines, Czech Republic, company share by value (%), 2008?09 69
Table 32: Topical OTC medicines, Czech Republic, value by company (CZKm), 2008?09 69
Table 33: Topical OTC medicines, Czech Republic, distribution channels by value (%), 2008?09 70
Table 34: Topical OTC medicines, Czech Republic, value by distribution channel (CZKm), 2008?09 70
Table 35: Cough and cold preparations, Czech Republic, value by segment (CZKm), 2004?09 72
Table 36: Cough and cold preparations, Czech Republic, value forecast by segment (CZKm), 2009?14 73
Table 37: Cough and cold preparations, Czech Republic, value by segment ($m), 2004?09 75
Table 38: Cough and cold preparations, Czech Republic, value forecast by segment ($m), 2009?14 76
Table 39: Cough and cold preparations, Czech Republic, brand share by value (%), 2008?09 78
Table 40: Cough and cold preparations, Czech Republic, value by brand (CZKm), 2008?09 78
Table 41: Cough and cold preparations, Czech Republic, company share by value (%), 2008?09 80
Table 42: Cough and cold preparations, Czech Republic, value by company (CZKm), 2008?09 80
Table 43: Cough and cold preparations, Czech Republic, distribution channels by value (%), 2008?09 81
Table 44: Cough and cold preparations, Czech Republic, value by distribution channel (CZKm), 2008?09 81
Table 45: Indigestion preparations, Czech Republic, value by segment (CZKm), 2004?09 83
Table 46: Indigestion preparations, Czech Republic, value forecast by segment (CZKm), 2009?14 84
Table 47: Indigestion preparations, Czech Republic, value by segment ($m), 2004?09 86
Table 48: Indigestion preparations, Czech Republic, value forecast by segment ($m), 2009?14 86
Table 49: Indigestion preparations, Czech Republic, brand share by value (%), 2008?09 88
Table 50: Indigestion preparations, Czech Republic, value by brand (CZKm), 2008?09 88
Table 51: Indigestion preparations, Czech Republic, company share by value (%), 2008?09 90
Table 52: Indigestion preparations, Czech Republic, value by company (CZKm), 2008?09 90
Table 53: Indigestion preparations, Czech Republic, distribution channels by value (%), 2008?09 91
Table 54: Indigestion preparations, Czech Republic, value by distribution channel (CZKm), 2008?09 91
Table 55: Medicated skin products, Czech Republic, value by segment (CZKm), 2004?09 93
Table 56: Medicated skin products, Czech Republic, value forecast by segment (CZKm), 2009?14 94
Table 57: Medicated skin products, Czech Republic, value by segment ($m), 2004?09 96
Table 58: Medicated skin products, Czech Republic, value forecast by segment ($m), 2009?14 97
Table 59: Medicated skin products, Czech Republic, brand share by value (%), 2008?09 99
Table 60: Medicated skin products, Czech Republic, value by brand (CZKm), 2008?09 99
Table 61: Medicated skin products, Czech Republic, company share by value (%), 2008?09 101
Table 62: Medicated skin products, Czech Republic, value by company (CZKm), 2008?09 101
Table 63: Medicated skin products, Czech Republic, distribution channels by value (%), 2008?09 102
Table 64: Medicated skin products, Czech Republic, value by distribution channel (CZKm), 2008?09 102
Table 65: First aid kits, Czech Republic, value (CZKm), 2004?09 104
Table 66: First aid kits, Czech Republic, value forecast (CZKm), 2009?14 105
Table 67: First aid kits, Czech Republic, value ($m), 2004?09 106
Table 68: First aid kits, Czech Republic, value forecast ($m), 2009?14 106
Table 69: First aid kits, Czech Republic, brand share by value (%), 2008?09 107
Table 70: First aid kits, Czech Republic, value by brand (CZKm), 2008?09 107
Table 71: First aid kits, Czech Republic, company share by value (%), 2008?09 108
Table 72: First aid kits, Czech Republic, value by company (CZKm), 2008?09 108
Table 73: First aid kits, Czech Republic, distribution channels by value (%), 2008?09 109
Table 74: First aid kits, Czech Republic, value by distribution channel (CZKm), 2008?09 109
Table 75: Other OTC healthcare products, Czech Republic, value by segment (CZKm), 2004?09 111
Table 76: Other OTC healthcare products, Czech Republic, value forecast by segment (CZKm), 2009?14 112
Table 77: Other OTC healthcare products, Czech Republic, value by segment ($m), 2004?09 114
Table 78: Other OTC healthcare products, Czech Republic, value forecast by segment ($m), 2009?14 115
Table 79: Other OTC healthcare products, Czech Republic, brand share by value (%), 2008?09 117
Table 80: Other OTC healthcare products, Czech Republic, value by brand (CZKm), 2008?09 117
Table 81: Other OTC healthcare products, Czech Republic, company share by value (%), 2008?09 119
Table 82: Other OTC healthcare products, Czech Republic, value by company (CZKm), 2008?09 119
Table 83: Other OTC healthcare products, Czech Republic, distribution channels by value (%), 2008?09 120
Table 84: Other OTC healthcare products, Czech Republic, value by distribution channel (CZKm), 2008?09 120
Table 85: Plasters & bandages, Czech Republic, value by segment (CZKm), 2004?09 122
Table 86: Plasters & bandages, Czech Republic, value forecast by segment (CZKm), 2009?14 123
Table 87: Plasters & bandages, Czech Republic, value by segment ($m), 2004?09 125
Table 88: Plasters & bandages, Czech Republic, value forecast by segment ($m), 2009?14 126
Table 89: Plasters & bandages, Czech Republic, brand share by value (%), 2008?09 128
Table 90: Plasters & bandages, Czech Republic, value by brand (CZKm), 2008?09 128
Table 91: Plasters & bandages, Czech Republic, company share by value (%), 2008?09 130
Table 92: Plasters & bandages, Czech Republic, value by company (CZKm), 2008?09 130
Table 93: Plasters & bandages, Czech Republic, distribution channels by value (%), 2008?09 131
Table 94: Plasters & bandages, Czech Republic, value by distribution channel (CZKm), 2008?09 131
Table 95: Traditional medicines, Czech Republic, value (CZKm), 2004?09 133
Table 96: Traditional medicines, Czech Republic, value forecast (CZKm), 2009?14 134
Table 97: Traditional medicines, Czech Republic, value ($m), 2004?09 135
Table 98: Traditional medicines, Czech Republic, value forecast ($m), 2009?14 135
Table 99: Traditional medicines, Czech Republic, brand share by value (%), 2008?09 136
Table 100: Traditional medicines, Czech Republic, value by brand (CZKm), 2008?09 136
Table 101: Traditional medicines, Czech Republic, company share by value (%), 2008?09 138
Table 102: Traditional medicines, Czech Republic, value by company (CZKm), 2008?09 138
Table 103: Traditional medicines, Czech Republic, distribution channels by value (%), 2008?09 139
Table 104: Traditional medicines, Czech Republic, value by distribution channel (CZKm), 2008?09 139
Table 105: Vitamins and minerals, Czech Republic, value by segment (CZKm), 2004?09 141
Table 106: Vitamins and minerals, Czech Republic, value forecast by segment (CZKm), 2009?14 142
Table 107: Vitamins and minerals, Czech Republic, value by segment ($m), 2004?09 144
Table 108: Vitamins and minerals, Czech Republic, value forecast by segment ($m), 2009?14 144
Table 109: Vitamins and minerals, Czech Republic, brand share by value (%), 2008?09 146
Table 110: Vitamins and minerals, Czech Republic, value by brand (CZKm), 2008?09 146
Table 111: Vitamins and minerals, Czech Republic, company share by value (%), 2008?09 148
Table 112: Vitamins and minerals, Czech Republic, value by company (CZKm), 2008?09 148
Table 113: Vitamins and minerals, Czech Republic, distribution channels by value (%), 2008?09 149
Table 114: Vitamins and minerals, Czech Republic, value by distribution channel (CZKm), 2008?09 149
Table 115: Global OTC healthcare market value, 2009 151
Table 116: Global OTC healthcare market split (value terms ($m), 2009), top five countries 154
Table 117: Leading players, top five countries 155
Table 118: Czech Republic OTC healthcare new product launches reports, by company, 2009 156
Table 119: Czech Republic OTC healthcare new product launches SKUs, by company, 2009 157
Table 120: Czech Republic OTC healthcare new product launches (reports), by flavor and fragrances, 2009 157
Table 121: Czech Republic OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2009 158
Table 122: Czech Republic OTC healthcare new product launches (reports), by package tags or claims, 2009 158
Table 123: Czech Republic OTC healthcare new product launches (2009) 159
Table 124: Czech Republic population, by age group, 2004?09 (millions) 160
Table 125: Czech Republic population forecast, by age group, 2009?14 (millions) 161
Table 126: Czech Republic population, by gender, 2004?09 (millions) 161
Table 127: Czech Republic population forecast, by gender, 2009?14 (millions) 162
Table 128: Czech Republic nominal GDP, 2004?09 (CZKbn, nominal prices) 162
Table 129: Czech Republic nominal GDP forecast, 2009?14 (CZKbn, nominal prices) 162
Table 130: Czech Republic real GDP, 2004?09 (CZKbn, 2000 prices) 163
Table 131: Czech Republic real GDP forecast, 2009?14 (CZKbn, 2000 prices) 163
Table 132: Czech Republic real GDP, 2004?09 ($bn, 2000 prices) 163
Table 133: Czech Republic real GDP forecast, 2009?14 ($bn, 2000 prices) 164
Table 134: Czech Republic consumer price index, 2004?09 (2000=100) 164
Table 135: Czech Republic consumer price index, 2009?14 (2000=100) 164

[Inhaltsverzeichnis ausblenden]

Hinweis:

* Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs

Warenkorb

OTC Healthcare in the Czech Republic to 2014

Copyright 2012 by dynamic technologies GmbH

	Weitere Studien von Datamonitor: Global Top 10 Chemicals Companies- Industry, Financial and SWOT Analysis Motorists Insight - Aftermarket Channel Analysis in Russia Saving for Retirement: The non-pension alternatives Wealth Management Competitor Tracker: June 2011 What Consumers Want: Current Accounts in Russia 2011 [Mehr...]